Acadian Asset Management LLC Lipocine Inc. Transaction History

Acadian Asset Management LLC

  • $32.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$0.3 - $0.58 $21,918 - $42,374
-73,060 Reduced 85.88%
12,010 $3,000
Q2 2022

Aug 09, 2022
BUY
$0.73 - $1.34 $62,101 - $113,993
85,070 New
85,070 $68,000
Q2 2019

Aug 08, 2019
SELL
$1.43 - $2.32 $25,677 - $41,657
-17,956 Closed
0 $0
Q1 2019

May 09, 2019
BUY
$1.46 - $2.33 $26,215 - $41,837
17,956 New
17,956 $41,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $433M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email